News and Trends 2 Nov 2022
Authorization given to BeiGene’s chemo-free treatment option for lymphoma
Marketing authorization has been granted to a drug to treat relapsed/refractory (R/R) marginal zone lymphoma (MZL) without chemotherapy, it was announced today (November 2). The European Commission (EC) gave the…